Earnings
EGRX
41.56
+0.87%
0.36
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
187.80M
187.80M
45.47M
142.34M
78.60M
30.79M
--
--
0.00
154.85M
--
32.95M
-2.02M
--
-8.26M
--
22.68M
10.69M
11.99M
--
11.99M
11.99M
--
--
0.87
FY 2019-12-31
195.89M
195.89M
60.90M
135.00M
76.37M
36.81M
--
--
0.00
174.08M
--
21.82M
-517.00K
--
700.00K
--
22.00M
7.68M
14.31M
--
14.31M
14.31M
--
--
1.01
FY 2018-12-31
213.31M
213.31M
61.92M
151.40M
60.51M
44.42M
--
--
-763.00K
176.70M
--
36.62M
-2.58M
--
--
--
34.04M
2.13M
31.90M
--
31.90M
31.90M
--
--
2.09
FY 2017-12-31
236.71M
236.71M
57.19M
179.52M
71.42M
32.61M
--
--
-7.38M
162.72M
--
73.99M
-1.04M
--
--
--
72.94M
17.60M
55.34M
--
55.34M
55.34M
-3.40M
--
3.48
FY 2016-12-31
189.48M
189.48M
55.31M
134.18M
52.31M
30.26M
--
--
--
136.13M
--
53.35M
76.00K
--
0.00
--
53.43M
-28.03M
81.45M
--
81.45M
81.45M
--
--
4.96

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out EGRX latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Eagle Pharms recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.